Cooperation between Ziv and Rambam

12/8/2013

During the conference, held at the Ziv Medical Center in July, physicians from Ziv and Rambam hospitals delivered presentations of severe clinical cases of glaucoma followed by professional discussions concerning treatment and surgery for patients suffering from glaucoma.

The conference was organized by Dr. Yossi Pikkel and Professor Eitan Blumenthal, respectively heads of Ziv and Rambam's Ophthalmology Departments.
Dr. Pikkel expressed his satisfaction with the conference, stating that "the importance of such an encounter lies in the opportunity physicians have to exchange information and brainstorm clinical situations which they meet daily. The participants benefit greatly from their participation in the conference, especially younger doctors who are exposed to thought processes and decisions as described by senior physicians from Ziv and Rambam."

In his concluding remarks, Professor Blumenthal emphasized the importance of creating an avenue of cooperation between the two departments, and the advantages inherent in such cooperation for doctors and patients alike."Establishing a forum in which physicians can share information as well as dilemmas with their colleagues who encounter similar situations in a wide variety of cases, creats a learning process, which will most certainly improve the services offered to the patients," he said.

Glaucoma is a disorder in which high optic pressure on the inner eye can lead to nerve damage and a deterioration of sight. The disorder affects approximately 3% of the population, appearing usually over the age of 50, with numbers increasing with age. Among people aged 80 and over, the prevalence of the disorder reaches 30% and is more common among people with diabetes. Risk factors are hereditary: pronounced short-sightedness, diabetes, low blood pressure and extensive use of steroids.

Glaucoma is known as the "silent thief of sight" because the loss of vision often occurs gradually over a long period of time, and people suffering from the disorder do not feel that their vision is impaired, until the disease is quite advanced when it is usually too late to cure it.